| Dr David W Lockwood, MD | |
|
13 Bay Tree Ln, Grantham, NH 03753-5408 | |
| (301) 806-1004 | |
| (603) 843-8492 |
| Full Name | Dr David W Lockwood |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 13 Bay Tree Ln, Grantham, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053385849 | NPI | - | NPPES |
| 113441800 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | D0005974 (Maryland) | Primary |
| Entity Name | Professional Services Of Holy Cross |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487692828 PECOS PAC ID: 3779516992 Enrollment ID: O20050916000745 |
News Archive
In a finding that helps resolve a long-standing question in developmental biology, Klaus H. Kaestner, PhD, Professor of Genetics, and colleagues report in the journal Developmental Cell this week about how the mammalian gut forms. Mice were genetically engineered to lack the protein Cdx2 in the cells that normally go on to form the stomach and intestine.
When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.
The Washington Post: "The health-care legislation signed into law in March provides a major boost to community health centers: $11 billion over five years. The first of these federally supported primary-care clinics opened in 1965." The law also provides funding designed to increase the supply of primary-care providers. And, "[o]n Wednesday, Secretary of Health and Human Services Kathleen Sebelius announced that the federal government will spend $250 million in programs to increase the number of doctors, nurses and other care providers.
Inhibiting a key enzyme that controls a large network of proteins important in cell division and growth paves the way for a new class of drugs that could stop glioblastoma, a deadly brain cancer, from growing.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David W Lockwood, MD Po Box 1340, Grantham, NH 03753-1340 Ph: (301) 806-1004 | Dr David W Lockwood, MD 13 Bay Tree Ln, Grantham, NH 03753-5408 Ph: (301) 806-1004 |
News Archive
In a finding that helps resolve a long-standing question in developmental biology, Klaus H. Kaestner, PhD, Professor of Genetics, and colleagues report in the journal Developmental Cell this week about how the mammalian gut forms. Mice were genetically engineered to lack the protein Cdx2 in the cells that normally go on to form the stomach and intestine.
When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.
The Washington Post: "The health-care legislation signed into law in March provides a major boost to community health centers: $11 billion over five years. The first of these federally supported primary-care clinics opened in 1965." The law also provides funding designed to increase the supply of primary-care providers. And, "[o]n Wednesday, Secretary of Health and Human Services Kathleen Sebelius announced that the federal government will spend $250 million in programs to increase the number of doctors, nurses and other care providers.
Inhibiting a key enzyme that controls a large network of proteins important in cell division and growth paves the way for a new class of drugs that could stop glioblastoma, a deadly brain cancer, from growing.
› Verified 7 days ago
Dr. Rebecca Lynne Johnson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7 Longwood Drive, Grantham, NH 03753 Phone: 603-863-1055 |